Medtide Inc. (Stock Code: 3880) Announces Positive Profit Alert

Bulletin Express

Feb 26

Medtide Inc. (泰德醫藥 (浙江) 股份有限公司) (Stock Code: 3880) announced that revenue for the year ended December 31, 2025 is expected to reach RMB555.00 million to RMB585.00 million, representing a year-on-year increase of 25.5% to 32.3% compared with the RMB442.20 million recorded in 2024.

The announcement further indicates that profit for 2025 is estimated to be in the range of RMB200.00 million to RMB230.00 million, marking an increase of 237.8% to 288.5% over the RMB59.20 million posted in the previous year. The adjusted net profit, a non-IFRS measure, is also forecast to be between RMB200.00 million and RMB230.00 million, up by approximately 16.3% to 33.7% compared with RMB172.00 million in 2024.

According to the announcement, the rise in revenue is attributed to the successful implementation of the “going with compound” strategy, leveraging an integrated CRDMO platform, and sustained demand from key customers. The boost in overall profit is driven by revenue growth, operational efficiencies, and fair value gains for 2025 related to financial liabilities at fair value through profit or loss. The final results for 2025 are expected to be published by the end of March 2026, subject to audit procedures.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1162146850"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1162146850\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1162146850?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-26 08:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162146850","market":"hk","top_or_hot":-1,"title":"Medtide Inc. (Stock Code: 3880) Announces Positive Profit Alert","media":"Bulletin Express","content":"<p>Medtide Inc. (泰德醫藥 (浙江) 股份有限公司) (Stock Code: 3880) announced that revenue for the year ended December 31, 2025 is expected to reach RMB555.00 million to RMB585.00 million, representing a year-on-year increase of 25.5% to 32.3% compared with the RMB442.20 million recorded in 2024.</p>\n<p>The announcement further indicates that profit for 2025 is estimated to be in the range of RMB200.00 million to RMB230.00 million, marking an increase of 237.8% to 288.5% over the RMB59.20 million posted in the previous year. The adjusted net profit, a non-IFRS measure, is also forecast to be between RMB200.00 million and RMB230.00 million, up by approximately 16.3% to 33.7% compared with RMB172.00 million in 2024.</p>\n<p>According to the announcement, the rise in revenue is attributed to the successful implementation of the “going with compound” strategy, leveraging an integrated CRDMO platform, and sustained demand from key customers. The boost in overall profit is driven by revenue growth, operational efficiencies, and fair value gains for 2025 related to financial liabilities at fair value through profit or loss. The final results for 2025 are expected to be published by the end of March 2026, subject to audit procedures.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Medtide Inc. (Stock Code: 3880) Announces Positive Profit Alert</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMedtide Inc. (Stock Code: 3880) Announces Positive Profit Alert\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-26 08:21</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Medtide Inc. (泰德醫藥 (浙江) 股份有限公司) (Stock Code: 3880) announced that revenue for the year ended December 31, 2025 is expected to reach RMB555.00 million to RMB585.00 million, representing a year-on-year increase of 25.5% to 32.3% compared with the RMB442.20 million recorded in 2024.</p>\n<p>The announcement further indicates that profit for 2025 is estimated to be in the range of RMB200.00 million to RMB230.00 million, marking an increase of 237.8% to 288.5% over the RMB59.20 million posted in the previous year. The adjusted net profit, a non-IFRS measure, is also forecast to be between RMB200.00 million and RMB230.00 million, up by approximately 16.3% to 33.7% compared with RMB172.00 million in 2024.</p>\n<p>According to the announcement, the rise in revenue is attributed to the successful implementation of the “going with compound” strategy, leveraging an integrated CRDMO platform, and sustained demand from key customers. The boost in overall profit is driven by revenue growth, operational efficiencies, and fair value gains for 2025 related to financial liabilities at fair value through profit or loss. The final results for 2025 are expected to be published by the end of March 2026, subject to audit procedures.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03880","symbol_name":"泰德医药","start_time":0,"source_url":"","article_id":"1162146850","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162146850","pubTimestamp":1772065266,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Medtide Inc. (泰德醫藥 (浙江) 股份有限公司) (Stock Code: 3880) announced that revenue for the year ended December 31, 2025 is expected to reach RMB555.00 million to RMB585.00 million, representing a year-on-year...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03880":"泰德医药"},"translate_title":"Medtide Inc.（股份代号：3880）公布正面盈利预警","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03880":1},"content_text":"Medtide Inc. (泰德醫藥 (浙江) 股份有限公司) (Stock Code: 3880) announced that revenue for the year ended December 31, 2025 is expected to reach RMB555.00 million to RMB585.00 million, representing a year-on-year increase of 25.5% to 32.3% compared with the RMB442.20 million recorded in 2024.\nThe announcement further indicates that profit for 2025 is estimated to be in the range of RMB200.00 million to RMB230.00 million, marking an increase of 237.8% to 288.5% over the RMB59.20 million posted in the previous year. The adjusted net profit, a non-IFRS measure, is also forecast to be between RMB200.00 million and RMB230.00 million, up by approximately 16.3% to 33.7% compared with RMB172.00 million in 2024.\nAccording to the announcement, the rise in revenue is attributed to the successful implementation of the “going with compound” strategy, leveraging an integrated CRDMO platform, and sustained demand from key customers. The boost in overall profit is driven by revenue growth, operational efficiencies, and fair value gains for 2025 related to financial liabilities at fair value through profit or loss. The final results for 2025 are expected to be published by the end of March 2026, subject to audit procedures.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}